Blood Screening Market Rising Demand and Emerging Growth Opportunities

The global Blood Screening Market is expanding as demand increases for safe blood supplies, advanced screening technologies, and improved detection of infectious diseases. Growing blood donation initiatives, investments in research and development, technological advancements, and the need for reliable screening solutions are supporting market development across regions. The market analysis covers North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa, providing a global view of market growth through 2031.

According to The Insight Partners, the Blood Screening Market size is expected to reach US$ 6.73 billion by 2031. The market was valued at US$ 3.59 billion in 2024 and is anticipated to register a CAGR of 9.4% during 2025–2031. The report evaluates the market by technology, product and service, end user, and geography, providing insights into the factors shaping market growth and future opportunities.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006182

Blood Screening Market Size and Growth:

The Blood Screening Market size is a key indicator of the increasing demand for technologies and services designed to support blood safety and screening activities. The market is projected to grow from US$ 3.59 billion in 2024 to US$ 6.73 billion by 2031. During the forecast period from 2025 to 2031, the market is expected to record a CAGR of 9.4%. The report also identifies a total addressable market of approximately US$ 36.58 billion during 2025–2031. This assessment reflects the broader commercial opportunity associated with blood screening technologies, products, services, and end users across global markets.

Blood Screening Market Segmentation:

The Blood Screening Market is segmented according to technology, product and service, and end user. By technology, the market includes Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Western Blot Assay, Next-Generation Sequencing, and Rapid Tests.

By product and service, the market is divided into Reagents and Kits, Instruments, Software, and Services. By end user, the market covers Hospitals and Blood Banks. These segments provide a structured view of how blood screening solutions are adopted across healthcare and laboratory environments.

Key Trends in the Blood Screening Market:

Several trends are influencing the development of the Blood Screening Market. The rise in chronic diseases and infectious outbreaks is increasing the need for blood screening for safety and early diagnosis. Technological advancements are also supporting the adoption of next-generation sequencing and other advanced screening technologies intended to improve screening accuracy. Regulatory requirements related to blood safety and standardization represent another important market trend. Companies operating in the industry need to address regulatory requirements while developing and implementing screening solutions.

Blood Screening Market Growth Drivers:

Investment in research and development by key players is one of the factors supporting Blood Screening Market growth. Leading companies are investing in research and development to introduce new products and expand adoption of screening solutions. Government and nonprofit initiatives are also contributing to market development. Blood donation campaigns can increase the availability of safe blood while supporting the need for effective screening. In addition, expansion of blood donations creates opportunities for companies to develop screening solutions that address growing demand.

Emerging Opportunities:

The Blood Screening Market presents opportunities in infectious disease detection, personalized medicine, and point-of-care testing. Increasing infectious disease outbreaks are driving demand for screening solutions that emphasize speed and accuracy. Personalized medicine represents another opportunity through the incorporation of genetic and biomarker testing into blood screening. Meanwhile, the growing requirement for decentralized testing is creating opportunities for portable blood screening systems, particularly in underserved regions.

Buy Premium Report: https://www.theinsightpartners.com/buy/TIPRE00006182

Top Key Players in the Blood Screening Market:

The Blood Screening Market includes several established companies and industry participants. Key companies profiled in the report include:

BD
Beckman Coulter, Inc.
Thermo Fisher Scientific Inc.
Siemens
Bio-Rad Laboratories, Inc.
Abbott
Hoffmann-La Roche Ltd
Grifols, S.A.
bioMérieux SA
Ortho Clinical Diagnostics

The report also identifies DIAsource ImmunoAssays, IBL International A Tecan Company, PerkinElmer Inc, DRG International Inc, MP Biomedicals LLC, Cisbio, Euro Diagnostica AB, and DiaSorin S.p.A. among companies associated with the market.

Blood Screening Market Future Outlook:

The future outlook for the Blood Screening Market is supported by continued demand for blood safety, increasing infectious disease screening requirements, technological advancements, and expansion of blood donation programs. The projected increase to US$ 6.73 billion by 2031 and a CAGR of 9.4% from 2025 to 2031 indicate continued market expansion during the forecast period. Technological developments, including next-generation sequencing, can contribute to improvements in screening capabilities, while personalized medicine and point-of-care testing provide additional areas of opportunity. At the same time, regulatory requirements and technology costs remain important considerations for market participants.

Trending Reports:

Blood Screening Market Growth, Size, Share, Trends, Key Players and Forecast by 2031
Adiponectin Testing Market Demand, Trends & Forecast by 2034
Ambulance Equipment Market Opportunities, Forecast, Size, Competitive Analysis till 2031

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in semiconductor and electronics, aerospace and defense, automotive and transportation, biotechnology, healthcare IT, manufacturing and construction, medical devices, technology, media and telecommunications, and chemicals and materials.